# FDA Inspection 818852 - Biomat USA Inc - February 13, 2013

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/7a014745-aa10-4230-ae85-ef8937230b15
Source feed: FDA_Inspections

> FDA Inspection 818852 for Biomat USA Inc on February 13, 2013. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 818852
- Company Name: Biomat USA Inc
- Inspection Date: 2013-02-13
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1233249 - 2024-02-22](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/6e99a717-57f4-4a89-b37c-9eb65931b050)
- [FDA Inspection 1059746 - 2018-07-20](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/fbec913a-a6fb-4391-a4cc-6d977cd24933)
- [FDA Inspection 1028540 - 2017-07-26](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/f1368aa7-3674-4ce3-a34c-f2976775115f)

Company: https://www.keypedia.com/companies/biomat-usa-inc/9d1438d7-64db-46c9-a3da-692f1de07360

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d